Quality of clinical practice guidelines for glycemic control in type 2 diabetes mellitus.

<h4>Background</h4>Several studies have reported that clinical practice guidelines (CPGs) in a variety of clinical areas are of modest or variable quality. The objective of this study was to evaluate the quality of an international cohort of CPGs that provide recommendations on pharmaceu...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Haley K Holmer, Lauren A Ogden, Brittany U Burda, Susan L Norris
Formato:	article
Lenguaje:	EN
Publicado:	Public Library of Science (PLoS) 2013
Materias:	Medicine R Science Q
Acceso en línea:	https://doaj.org/article/b9b07271157749e984245874f7314e6b
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:b9b07271157749e984245874f7314e6b
record_format	dspace
spelling	oai:doaj.org-article:b9b07271157749e984245874f7314e6b2021-11-18T07:50:32ZQuality of clinical practice guidelines for glycemic control in type 2 diabetes mellitus.1932-620310.1371/journal.pone.0058625https://doaj.org/article/b9b07271157749e984245874f7314e6b2013-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23577058/?tool=EBIhttps://doaj.org/toc/1932-6203<h4>Background</h4>Several studies have reported that clinical practice guidelines (CPGs) in a variety of clinical areas are of modest or variable quality. The objective of this study was to evaluate the quality of an international cohort of CPGs that provide recommendations on pharmaceutical management of glycemic control in patients with type 2 diabetes mellitus (DM2).<h4>Methods and findings</h4>We searched the National Guideline Clearinghouse (NGC) on February 15th and June 4th, 2012 for CPGs meeting inclusion criteria. Two independent assessors rated the quality of each CPG using the Appraisal of Guidelines for Research & Evaluation II (AGREE II) instrument. Twenty-four guidelines were evaluated, and most had high scores for clarity and presentation. However, scope and purpose, stakeholder involvement, rigor of development, and applicability domains varied considerably. The majority of guidelines scored low on editorial independence, and only seven CPGs were based on an underlying systematic review of the evidence.<h4>Conclusions</h4>The overall quality of CPGs for glycemic control in DM2 is moderate, but there is substantial variability among quality domains within and across guidelines. Guideline users need to be aware of this variability and carefully appraise and select the guidelines that they apply to patient care.Haley K HolmerLauren A OgdenBrittany U BurdaSusan L NorrisPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 8, Iss 4, p e58625 (2013)
institution	DOAJ
collection	DOAJ
language	EN
topic	Medicine R Science Q
spellingShingle	Medicine R Science Q Haley K Holmer Lauren A Ogden Brittany U Burda Susan L Norris Quality of clinical practice guidelines for glycemic control in type 2 diabetes mellitus.
description	<h4>Background</h4>Several studies have reported that clinical practice guidelines (CPGs) in a variety of clinical areas are of modest or variable quality. The objective of this study was to evaluate the quality of an international cohort of CPGs that provide recommendations on pharmaceutical management of glycemic control in patients with type 2 diabetes mellitus (DM2).<h4>Methods and findings</h4>We searched the National Guideline Clearinghouse (NGC) on February 15th and June 4th, 2012 for CPGs meeting inclusion criteria. Two independent assessors rated the quality of each CPG using the Appraisal of Guidelines for Research & Evaluation II (AGREE II) instrument. Twenty-four guidelines were evaluated, and most had high scores for clarity and presentation. However, scope and purpose, stakeholder involvement, rigor of development, and applicability domains varied considerably. The majority of guidelines scored low on editorial independence, and only seven CPGs were based on an underlying systematic review of the evidence.<h4>Conclusions</h4>The overall quality of CPGs for glycemic control in DM2 is moderate, but there is substantial variability among quality domains within and across guidelines. Guideline users need to be aware of this variability and carefully appraise and select the guidelines that they apply to patient care.
format	article
author	Haley K Holmer Lauren A Ogden Brittany U Burda Susan L Norris
author_facet	Haley K Holmer Lauren A Ogden Brittany U Burda Susan L Norris
author_sort	Haley K Holmer
title	Quality of clinical practice guidelines for glycemic control in type 2 diabetes mellitus.
title_short	Quality of clinical practice guidelines for glycemic control in type 2 diabetes mellitus.
title_full	Quality of clinical practice guidelines for glycemic control in type 2 diabetes mellitus.
title_fullStr	Quality of clinical practice guidelines for glycemic control in type 2 diabetes mellitus.
title_full_unstemmed	Quality of clinical practice guidelines for glycemic control in type 2 diabetes mellitus.
title_sort	quality of clinical practice guidelines for glycemic control in type 2 diabetes mellitus.
publisher	Public Library of Science (PLoS)
publishDate	2013
url	https://doaj.org/article/b9b07271157749e984245874f7314e6b
work_keys_str_mv	AT haleykholmer qualityofclinicalpracticeguidelinesforglycemiccontrolintype2diabetesmellitus AT laurenaogden qualityofclinicalpracticeguidelinesforglycemiccontrolintype2diabetesmellitus AT brittanyuburda qualityofclinicalpracticeguidelinesforglycemiccontrolintype2diabetesmellitus AT susanlnorris qualityofclinicalpracticeguidelinesforglycemiccontrolintype2diabetesmellitus
_version_	1718422876637364224

Quality of clinical practice guidelines for glycemic control in type 2 diabetes mellitus.

Ejemplares similares